OSCR
Get informed when a big investor buys or sells
+ FollowUndervalued by 68.4% based on the discounted cash flow analysis.
| Market cap | $8.65 Billion |
|---|---|
| Enterprise Value | $5.01 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.69 |
| Beta | 2.47 |
| Outstanding Shares | 302,220,000 |
| P/E Ratio | 19.51 |
|---|---|
| PEG | -7.55 |
| Price to Sales | 0.69 |
| Price to Book Ratio | 5.72 |
| Enterprise Value to Revenue | 0.33 |
| Enterprise Value to EBIT | 7.92 |
| Enterprise Value to Net Income | 9 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.21 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 83.98% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.48%▼ 65.81% |
|---|---|
| Total Invested | $44.83M▼ 99.21% |
| Investors Holding | 8▼ 436.00% |
No data
Headquartered in New York City, Oscar has been challenging the health care s\stem's status quo since our founding in 2012. The compan\Ŗs member-ırst philosoph\ and innovative approach to care has earned us the trust of approxim...